IBM's Watson to Help Unlock Life-saving Insights from Cancer Patient DNA
Date added: 19 Mar 2014
New York, NY/March 19, 2014 - Dr. Robert Darnell (left), CEO of the New York Genome Center, and Dr. Ajay Royyuru, Director of the IBM Computational Biology Center (right) discuss how IBM's Watson will be used to make sense of vast amounts of genetic sequencing data and medical information to identify personalized treatments for cancer patients, at an event at the New York Genome Center in New York City on March 19, 2014. IBM and NYGC will soon begin testing a Watson prototype designed specifically for genomic research to help oncologists deliver unique, customized cancer treatments according to an individual patient's DNA. Photo Credit: Jon Simon/Feature Photo Service for IBM.